StockVS

NASDAQ · Medical Devices · USD

Mobia Medical, Inc. (MOBI) Stock Analysis

Mobia Medical, Inc. (MOBI) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

MOBI

$11.63

$0.00 (0.00%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare MOBI with… →

MOBI Key Statistics

As of Sep 4, 2026
Trading
Open
$11.62
Previous Close
$11.63
Day's Range
11.25–11.81
52-Week Range
10.19–15.29
Volume
97.60K
Valuation
Market Cap
$387.18M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
8.55
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.91
Financials (FY)
Revenue (FY)
$32.04M+104.81%
Net Income (FY)
−$46.50M
Profit marginThe share of revenue left as profit after all costs and taxes.
−141.63%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
33.29M
Dividend and dates
Earnings Date
November 9, 2026
Avg Volume
151.26K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

MOBI Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$32.04M−$46.50M−145.1%
2024$15.64M−$24.60M−157.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$32.04M$25.98M−$46.37M−$46.50M−145.1%
2024$15.64M$12.45M−$24.24M−$24.60M−157.3%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

MOBI Valuation vs Medical Devices Median

Median of 151 stocks
MetricMOBIMedical Devices medianvs median
P/S ratio8.552.98187% above
Profit margin−141.63%−1.69%139.9 pts below

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 7 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Mobia Medical, Inc. (MOBI) at $387.18M. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 167.

Over the past 52 weeks the price has ranged from $10.19 to $15.29. MOBI last closed at $11.63 on September 4, 2026. The close was unchanged from the previous session. The latest close sits 14.13% above that 52-week low.

Financial Health

In fiscal 2025, Mobia Medical, Inc. reported revenue of $32.04M. That is +104.81% against the prior fiscal year, when revenue was $15.64M. The same year closed with a net loss of $46.50M. Profit margin runs at −141.63%. That is 139.9 percentage points below the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to −1.91.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 8.55 times revenue. On price-to-sales that is 187.28% above the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

Growth & Income

The record shows no dividend for MOBI.

So far in 2026 the price is −1.02%.

Peer Comparison

Mobia Medical, Inc. (MOBI) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Mobia Medical, Inc. MOBI $387.18M
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Mobia Medical, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

View all Medical Devices stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About Mobia Medical, Inc.

Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.

Visit website →